Link

MHRA Drug Safety Update May 2017

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (vol 10, issue 10, May 2017) has been published and includes articles on:

  • Finasteride: rare reports of depression and suicidal thoughts;
  • New e-learning modules on reporting suspected adverse drug reactions; and
  • Letters sent to healthcare professionals in April 2017, including reminder of retigabine (Trobalt) withdrawal.